Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.985 USD | +1.61% | +2.95% | -8.63% |
May. 13 | Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Terns Pharmaceuticals, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.63% | 381M | |
+29.64% | 48.16B | |
-0.77% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.47% | 25.59B | |
-22.93% | 18.96B | |
+8.46% | 12.92B | |
+29.06% | 12.03B | |
-2.06% | 11.77B |
- Stock Market
- Equities
- TERN Stock
- News Terns Pharmaceuticals, Inc.
- BMO Capital Adjusts Price Target on Terns Pharmaceuticals to $19 From $18, Maintains Outperform Rating